S&P Global Ratings upgraded Vizient Inc.'s corporate credit rating to B+ from B.
The outlook is stable.
S&P said the upgrade takes into account the company's largely complete integration of competitor MedAssets Inc.'s group purchasing organization and analytics and consulting business.
Vizient acquired MedAssets' Spend and Clinical Management segment in early 2016. S&P said leverage is trending lower than expected, adding that it expects acquisition and integration charges will be modest and the company will start generating moderate discretionary cash flow.
The rating agency also believes the deal has reduced the company's appetite for acquisitions and expects acquisition activity to be limited to tuck-in acquisitions.
S&P said the stable outlook reflects its expectation that Vizient will limit acquisition activity to tuck-in acquisitions, its restructuring and integration charges will be modest and it will begin generating moderate free cash flow, resulting in a decline in leverage.
S&P Global Ratings and S&P Global Market Intelligence are owned by S&P Global Inc.